So true.😷💪

👍😷❤️

👍😷💪

👍👍👍

😥 It's heartbreaking.

Thank you for your work!👍

Repeated COVID (infections) are ruining education.

People like to attribute kids failing to do the work to the few months they spent at home in 2020. Choosing to ignore that Covid causes measurable brain impairment and cumulative cognitive deficits in not only adults, but children too.

❤️😥

Sadly there is a reason😥
bsky.app/profile/chim...

Absolutely. And it breaks my heart.

Very,very true.

I get you. It was just a dark, sad thought I had.

And then releasing a brain numbing AI to a population already shattered with Covid brain damage. Ideocracy here we come.🥺

😥😥

😂😂

Jetzt, wo es immer weniger Zeitzeugen gibt, liegt es an uns, der nächsten Generation, die Erinnerung wachzuhalten. An
#Auschwitz und all die anderen furchbaren Lager.

Meine 16jährige Tante im Lager in Braunschweig 1940:

💪😷💪

Mucosal vaccination in mice provides protection from diverse respiratory threats Traditional vaccines target specific pathogens, limiting their scope against diverse respiratory threats. We describe an intranasal liposomal formulation combining toll-like receptor (TLR) 4 and 7/8 ligands with a model antigen, ovalbumin, that provided ...

www.science.org/doi/10.1126/...

👍😷

SARS-CoV-2 directly infects the inner ear and causes hearing dysfunction SARS-CoV-2 directly infects spiral ganglion neurons in the inner ear, causing apoptosis and hearing loss. Liu et al. show that the spike protein inhibits mTOR signaling, inducing aberrant stress granu...

«Studien zeigen: SARS-CoV-2 kann das #Gehör schädigen. In Mäusen dringt das Virus #ins Innenohr ein und greift Nervenzellen an. Das Spike-Protein stört wichtige Zellprozesse, was zum Zelltod führt. Hörverlust kann so auch ohne Entzündung entstehen.»

www.cell.com/cell-reports...

#COVID19 #SARSCoV2

😷👍🥰

Accelerating Development for Some NextGen Covid Vaxes (Update No 39) - Absolutely Maybe Several next generation Covid vaccines are now advancing into mid- or late-stage trials. So this month, I have started a new section—a…

Hilda Bastians Update
"Several next generation Covid vaccines are now advancing into mid- or late-stage trials."

New section: Watchlist of featured vaccines that are both at more advanced stages of development, and reporting ongoing recent progress.

absolutelymaybe.plos.org/2026/04/02/a...
#COVID

a little girl is hugging a blue monster from monsters inc Alt: a little girl is hugging a blue monster from monsters inc

Feel U.

I love writing. Why would I ever want to stop doing it??

Tue ich schon seit 15 Jahren nicht mehr👍💪

Montreal Clinical Research Institute 103 participants study finds gut bacteria release tiny vesicles that can travel to the brain, trigger inflammation, and may drive long COVID brain fog by disrupting the gut brain link.

www.researchsquare.com/article/rs-8...

😄😄

A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2 Hu, B., Guo, H., Zhou, P. & Shi, Z. L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141–154 (2021). Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3–20 (2022). Almanza, G. et al. Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern. PLoS Pathog. 18, e1010686 (2022). Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J. & Peiffer-Smadja, N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin. Microbiol. Infect. 28, 202–221 (2022). Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z. & Pierce, B. F. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat. Rev. Immunol. 21, 626–636 (2021). Alter, G. et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature 596, 268–272 (2021). Emary, K. R. W. et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet 397, 1351–1362 (2021). Jones, I. & Roy, P. Sputnik V COVID-19 vaccine candidate appears safe and...

A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2
->Nature | More on "mRNA vaccine SARS-CoV-2 protection" at BigEarthData.ai | #Health #Coronavirus #Vaccine

😂😂😂

💪😷👍